The U.S. Preventive Services Task Force today recommended clinicians offer pre-exposure prophylaxis (PrEP), a pill that helps prevent the spread of HIV, to high-risk patients. High-risk behaviors include having a sex partner with HIV, having sex without a condom with a partner at high risk for HIV and sharing needles or other equipment while injecting drugs, the panel said. PrEP is highly effective at preventing HIV if taken daily, but people who take the pill should continue to use condoms and practice other behaviors to reduce their risk of other sexually transmitted infections, the task force said. It also continued to recommend that clinicians screen for HIV in pregnant women, everyone aged 15 to 65, and others at increased risk for HIV. The panel assigned an “A" grade to the recommendations, meaning all copays and deductibles would be waived under the Affordable Care Act.

Related News Articles

Headline
The Supreme Court June 27 voted 6-3 to uphold an Affordable Care Act provision creating an independent task force charged with making recommendations of…
Headline
A study published June 25 by the Journal of the American Heart Association found that heart disease death rates fell 66% from 1970 to 2022. Deaths from heart…
Headline
The White House May 22 released its Make America Healthy Again report that focuses on childhood chronic disease. The report highlights findings from the MAHA…
Headline
The Food and Drug Administration May 16 announced it cleared the first blood test to diagnose Alzheimer’s disease. The test, created by Fujirebio Diagnostics,…
Headline
The National Institutes of Health May 8 released an analysis that found incidences of 14 types of cancer increased among people under age 50 from 2010-2019.…
Headline
A New England Journal of Medicine study published yesterday found success in administering dostarlimab, an immunotherapy drug, to a group of 103 cancer…